Envista Holdings (NVST) Share-based Compensation (2018 - 2026)
Envista Holdings' (NVST) quarterly Share-based Compensation came in at $6.0 million in Q2 2026, down 15.49% year-on-year from $7.1 million in Q2 2025, and down 69.7% quarter-over-quarter from $19.8 million in Q4 2025.
Envista Holdings (NVST) Share-based Compensation (2018 - 2026) Analysis & Trends
Envista Holdings' Share-based Compensation history runs 9 years deep, the most recent figure standing at $6.0 million for Q2 2026.
- On a quarterly basis, Share-based Compensation fell 15.49% year-over-year to $6.0 million in Q2 2026; TTM through Apr 2026 was $23.7 million, a 2533.33% increase from a year earlier, with the FY2025 full-year figure at $24.8 million, up 367.92% from the prior year.
- Share-based Compensation fell to $6.0 million in Q2 2026 per NVST's latest filing, from $19.8 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $41.1 million in Q3 2024 and bottomed at -$39.2 million in Q4 2024.
- The 5-year median for Share-based Compensation is $7.1 million (2025), against an average of $5.2 million.
- Across the five-year window, Share-based Compensation soared 10900.0% in 2022 and sank 575.0% in 2024, its largest moves.
- Year by year, Share-based Compensation stood at $21.6 million in 2022, then slumped by 33.8% to $14.3 million in 2023, then tumbled by 374.13% to -$39.2 million in 2024, then jumped by 150.51% to $19.8 million in 2025, then slumped by 69.7% to $6.0 million in 2026.
- Per Business Quant, the three latest NVST Share-based Compensation figures stand at $6.0 million (Q2 2026), $19.8 million (Q4 2025), and $700000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 45.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 13.10 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 58.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 26.79 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 51.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 40.92 Mn |
| 10 | Envista Holdings | 4.29 Bn | 3.20 Bn | 390.10 Mn | 6.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 6.00 Mn |
| Apr 3, 2026 | 6.00 Mn |
| Dec 31, 2025 | 19.80 Mn |
| Dec 31, 2025 | 19.80 Mn |
| Sep 26, 2025 | 700,000.00 |
| Sep 26, 2025 | 700,000.00 |
| Jun 27, 2025 | -2.80 Mn |
| Jun 27, 2025 | -2.80 Mn |
| Mar 28, 2025 | 7.10 Mn |
| Mar 28, 2025 | 7.10 Mn |
| Dec 31, 2024 | -39.20 Mn |
| Dec 31, 2024 | -39.20 Mn |
| Sep 27, 2024 | 41.10 Mn |
| Sep 27, 2024 | 41.10 Mn |
| Jun 28, 2024 | -8.10 Mn |
| Jun 28, 2024 | -8.10 Mn |
| Mar 29, 2024 | 11.50 Mn |
| Mar 29, 2024 | 11.50 Mn |
| Dec 31, 2023 | 14.30 Mn |
| Dec 31, 2023 | 14.30 Mn |